CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Evaluation studies on a tri-sodium citrate based novel formulation* for prevention and treatment of bovine mastitis

Author: 
Ram Bahal Rai, Tukaram Damodaran, Kuldeep Dhama, Sandip Chakraborty, Balvir Singh, Hamid Ali, Sweta Rai and Saminathan Mani
Subject Area: 
Health Sciences
Abstract: 

Mastitis is an inflammation of the mammary glands caused by several pathogens as well as circulating metabolites, injuries etc. and its prevention remains a challenge to the veterinarians. It is the second most economically significant disease standing next to foot and mouth disease (FMD). In mastitis, the standard treatment is antibiotic therapy (parental as well as intra- mammary infusions) apart from fomentation of udder accompanied by drainage of milk but the success rate is only reasonable. Between 1999-2012, the present long term study was conducted starting from Port Blair, Andaman & Nicobar Islands to Northern Plains of India. Animals from Military Dairy Farm, Experimental Dairy, owned by farmers in the villages and private un-organized dairies were included. The managemental conditions varied greatly and accordingly mastitis incidences also. Standard treatment, trisodium citrate and the present formulation have been evaluated considering that trisodium citrate helps in continuous milk production by making available citrate as substrate. It has been observed that clinical mastitis is predominant at 0-2 weeks of calving (67.3 %) while sub-clinical mastitis is predominant during 8-24 weeks period (96.6 %). The standard treatment given one day prior to expected day of calving did not have significant effect on prevention of onset of clinical mastitis during the first fortnight while tri-sodium citrate reduced the incidence to 6.9% against 29.2% in the control population during the period. The present formulation reduced the incidence to 1.3%. In the control untreated clinical mastitis cases, majority of cases developed fibrosis and restoration of milk was less than 10%. The animals who received standard treatment showed moderate recovery restoration of milk varied between 20-60% but 5.7% of the animals developed fibrosis. The animals treated with present formulation showed excellent recovery. The blood and flakes disappeared within 2-3 days, and the swelling subsided in 4-5 days. Milk recovery rate from the affected quarter (s) was between 60-80%. In case of animals affected with sub-clinical mastitis also the animals showed excellent recovery with the present formulation and flakes or blood disappeared by 2nd-3rd day and milk yield was restored. Thus it can be concluded that in comparison to standard antibiotic therapy, the present formulation is more efficacious and cost-effective as far as prevention and the recovery from clinical as well as sub-clinical mastitis is concerned. Its wide usage is recommended to lessen animal sufferings from this economically significant disease condition as well as enhancing milk production.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran